Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains.
暂无分享,去创建一个
C. L. La Porta | G. Russo | A. Aiuti | F. Citarella | A. Fantoni | C. Pietropaolo | M. Rinaldi | Claudia La Porta
[1] R. Cortese,et al. Biologically active recombinant prothrombin and antithrombin III expressed in a human hepatoma/vaccinia virus system , 1991, Biotechnology and applied biochemistry.
[2] K Fujikawa,et al. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. , 1991, The Journal of biological chemistry.
[3] B. Lämmle,et al. Purified Factor XII Has a Higher Specific Activity than the Parent Molecule in Plasma , 1991, Thrombosis and Haemostasis.
[4] R. Colman,et al. Mapping of a putative surface-binding site of human coagulation factor XII. , 1989, The Journal of biological chemistry.
[5] R. Colman,et al. Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor. , 1988, The Journal of clinical investigation.
[6] R. MacGillivray,et al. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region. , 1987, The Journal of biological chemistry.
[7] R. Colman,et al. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation. , 1987, The Journal of biological chemistry.
[8] M. Silverberg,et al. The coagulation-kinin pathway of human plasma , 1987 .
[9] R. Colman,et al. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. , 1986, Blood.
[10] H. Stunnenberg,et al. Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. , 1986, The EMBO journal.
[11] R. Cortese,et al. cDNA sequence coding for human coagulation factor XII (Hageman). , 1986, Nucleic acids research.
[12] R T MacGillivray,et al. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. , 1985, The Journal of biological chemistry.
[13] J. Cazenave,et al. Active γ-carboxylated human factor IX expressed using recombinant DNA techniques , 1985, Nature.
[14] K Fujikawa,et al. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor). , 1985, The Journal of biological chemistry.
[15] H. Saito,et al. Production and characterization of a murine monoclonal antibody against a heavy chain of Hageman factor (factor XII). , 1985, Blood.
[16] J. Luzio,et al. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. , 1984, The EMBO journal.
[17] R. Colman. Surface-mediated defense reactions. The plasma contact activation system. , 1984, The Journal of clinical investigation.
[18] H. Neurath,et al. Evolution of proteolytic enzymes. , 1984, Science.
[19] B. Moss,et al. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[20] K Fujikawa,et al. Amino acid sequence of human beta-factor XIIa. , 1983, The Journal of biological chemistry.
[21] B. Moss,et al. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[22] Ratnoff Od. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin. , 1980 .
[23] Y. Hojima,et al. Enzymatic properties of human Hageman factor fragment with plasma prekallikrein and synthetic substrates. , 1980, Thrombosis research.
[24] J. Griffin,et al. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma , 1978, The Journal of experimental medicine.
[25] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Cochrane,et al. The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule. , 1976, The Journal of clinical investigation.
[27] K. Austen,et al. A PREALBUMIN ACTIVATOR OF PREKALLIKREIN , 1971, The Journal of experimental medicine.
[28] Kaplan Ap,et al. A Pre-Albumin Activator of Prekallikrein , 1970 .
[29] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[30] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. 1977. , 1992, Biotechnology.
[31] E. Harlow,et al. Antibodies: A Laboratory Manual , 1988 .
[32] C. Kluft. Synthetic substrates for the assay of prekallikrein and factor XII. , 1988, Methods in enzymology.
[33] R. Colman,et al. Purification of human factor XII from plasma using zinc chelate affinity chromatography. , 1986, Thrombosis research.
[34] J. T. ten Cate,et al. Purification of Human Factor , 1977, Thrombosis and Haemostasis.